The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Point-Of-Care-Testing (POCT) Market Expected To Reach Based On Its 2026 Value?

The point-of-care-testing (poct) market size has experienced swift expansion in recent years. It is anticipated to grow from $50.79 billion in 2025 to $56.68 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.6%. The historical growth can be attributed to the rising prevalence of chronic diseases, a heightened requirement for rapid clinical decision-making, the expansion of emergency and critical care services, constrained access to centralized laboratories, and the demand for immediate diagnostic outcomes.

The point-of-care-testing (poct) market size is expected to show significant expansion in the next few years. It is projected to reach $86.91 billion by 2030, with a compound annual growth rate (CAGR) of 11.3%. The expansion anticipated during the forecast period is largely due to advancements in poct device miniaturization, the increasing availability of home care and remote patient monitoring, a rise in infectious disease outbreaks, the ongoing decentralization of healthcare, and the growing acceptance of self-testing diagnostics. Important trends expected in this period include a greater adoption of rapid diagnostic testing at the point of care, an increasing need for home-based and self-testing solutions, the broadening of over-the-counter diagnostic products, an intensified focus on early disease detection and screening, and improvements in the accuracy and sensitivity of poct devices.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

Which Strong Drivers Are Impacting The Point-Of-Care-Testing (POCT) Market Growth?

The expanding use of telemedicine is anticipated to fuel the growth of the point-of-care-testing (POCT) market in the future. Telemedicine involves delivering medical care remotely through digital communication tools such as video and phone calls, or secure messaging. This adoption is driven by an increasing need for convenient, timely, and contact-free healthcare, a demand significantly accelerated by the COVID-19 pandemic. Point-of-care testing (POCT) supports telemedicine by providing quick, dependable diagnostic results that can be immediately shared with distant healthcare providers. For instance, in April 2025, according to the American Hospital Association, a US-based professional organization, over 12.6% of Medicare beneficiaries utilized telehealth services in 2023. By 2036, the number of physicians is projected to reach up to 86,000. Telehealth plays a crucial role in helping to ease the growing physician shortage. As a result, the increasing adoption of telemedicine is propelling the expansion of the point-of-care-testing (POCT) market.

Which Segment Types Are Examined In The Point-Of-Care-Testing (POCT) Market Segment Study?

The point-of-care-testing (poct) market covered in this report is segmented –

1) By Type: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types

2) By Mode Of Purchase: Over-The-Counter Products, Prescribed Based Products

3) By Technology: Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing

4) By End-User: Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users

Subsegments:

1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices

2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing

3) By Cardiac Markers Testing: Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing

4) By Coagulation Testing: Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing

5) By Pregnancy And Fertility Testing: Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing

6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing

7) By Urinalysis Testing: Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing

8) By Other Types: Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

Which Trends Are Contributing To Changes In The Point-Of-Care-Testing (POCT) Market?

Major companies in the point-of-care testing (POCT) market are increasingly prioritizing technological advancements, such as microfluidic rapid antimicrobial-susceptibility testing (AST) systems, to address the growing need for faster, clinic-level diagnostics and improved antimicrobial stewardship in primary care. This microfluidic AST technology leverages fluid channels at the micrometer scale to culture and detect bacteria from patient samples—like urine—and determine their antibiotic susceptibility in a fraction of the time required by conventional culture-based methods, which can take several days. For example, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, introduced the PA 100 AST System, a compact POCT analyser that employs Sysmex Astrego’s proprietary microfluidic cartridges to detect bacteria in approximately 15 minutes and provide complete AST results in about 30 minutes. The system is highly user-friendly: healthcare professionals simply place the sample into a single-use cartridge, insert it into the desktop analyser, and receive automated AST readouts without needing specialized laboratory training. This rapid turnaround allows timely antibiotic decisions during the first patient visit, supporting efforts to reduce inappropriate prescriptions and combat antimicrobial resistance (AMR).

Which Players Are Part Of The Competitive Landscape Of The Point-Of-Care-Testing (POCT) Market?

Major companies operating in the point-of-care-testing (poct) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, BioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY, Accriva, ACON Laboratories, Sekisui Diagnostics, PTS Diagnostics, Meridian Bioscience

Get The Full Point-Of-Care-Testing (POCT) Market Report:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

Which Region Leads The Point-Of-Care-Testing (POCT) Market In Terms Of Market Share?

North America was the largest region in the point-of-care testing (POCT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (poct) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Point-Of-Care-Testing (POCT) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/point-of-care-testing-poct-global-market-report

Browse Through More Reports Similar to the Global Point-Of-Care-Testing (POCT) Market 2026, By The Business Research Company

Precast Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/precast-construction-global-market-report

Modular And Prefabricated Nonresidential Building Construction Market Report 2026

https://www.thebusinessresearchcompany.com/report/modular-and-prefabricated-nonresidential-building-construction-global-market-report

Ready Mix Concrete Market Report 2026

https://www.thebusinessresearchcompany.com/report/ready-mix-concrete-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model